Are your blood sugar spikes the worst after breakfast than other times of the day? Discover why normal, everyday hormones might be to blame, and how inhaled insulin can help you take back control. Taking a “hit” is common now – without the risk of being arrested!
[read_more text="read more" title="read more" url="https://tcoyd.org/2025/06/morning-blood-sugar-spikes/" align="left"]
Over the last two years, there’s been conflicting information in the news about GLP-1 medications and mental health. Some reports raised concerns about possible mood-related side effects, but others shared mental health benefits and broader therapeutic potential. Here’s what we know so far – and what still needs further research.
[read_more text="read more" title="read more" url="https://tcoyd.org/2025/04/ozempic-mounjaro-mental-health/" align="left"]
Dr. E gets personal in this month’s case study, sharing a recent experience he had of exercise-induced hypoglycemia with his hybrid closed-loop system. He offers four tips to avoid a blood sugar rollercoaster while working out with type 1 diabetes.
[read_more text="read more" title="read more" url="https://tcoyd.org/2025/03/type-1-diabetes-exercise-tips/" align="left"]
Ozempic and Mounjaro are similar in many ways, but there’s one key difference between the two. Learn how these blockbuster type 2 diabetes medications are changing the landscape of diabetes management, and find out why they aren’t yet approved for use in type 1.
[read_more text="read more" title="read more" url="https://tcoyd.org/2025/02/mounjaro-vs-ozempic-comparison/" align="left"]
2025 is shaping up to be a blockbuster year in diabetes care! From smart MDI systems to medications that pull triple duty, the future is looking smarter—and less invasive.
Here are several key advancements we expect to see in 2025.
